News

New promising ColoNode results

New promising ColoNode results

Umeå University, has in collaboration with HiloProbe AB completed the first part of a new clinical study of its ColoNode biomarker test, which provides further important evidence for the product ColoNode's benefits and usefulness in colon cancer. “The results look...

HiloProbe participates at major surgeon congress in Dublin

HiloProbe participates at major surgeon congress in Dublin

HiloProbe has participated in a major international surgeon congress in Dublin. - Surgeons are one of our main stakeholders and therefore it important to meet, discuss and present data to them, says Lina Olsson, CEO. HiloProbe participated at the well-attended ESCP...

HiloProbe CE-marks ColoNode

HiloProbe CE-marks ColoNode

HiloProbe has CE-marked the ColoNode to satisfy the needs of potential customers who want to start testing the product. - Research Use Only was not enough. Therefore, we have put a lot of focus and resources into completing CE documentation according to IVDD in order...

Hiloprobe föreläser på Cancerdagen

Hiloprobe föreläser på Cancerdagen

Den 6 oktober deltog Hiloprobe på Cancerdagen. Här kan du se hela föreläsningen. Det var Marie-Louise Hammarström, professor vid institutionen för klinisk mikrobiologi, Umeå universitet, som på Cancerdagen talade om ett nytt lymfkörteltest för stadieindelning och...

Hiloprobe deltar på Cancerdagen

Hiloprobe deltar på Cancerdagen

Hiloprobe deltar på Cancerdagen den 6 oktober för att presentera de nya möjligheter som deras diagnostik-kit Colonode kan ge för behandling av kolorektalcancer. Marie-Louise Hammarström, professor vid institutionen för klinisk mikrobiologi, Umeå universitet, ska tala...

HiloProbe Awarded SEK 2 Million by Swedish Innovation Agency

HiloProbe Awarded SEK 2 Million by Swedish Innovation Agency

HiloProbe has been granted SEK 2 million from Swedish Innovation Agency Vinnova to validate a product that detects and helps treat people with colorectal cancer. “This is an important grant for us and means we can validate our product and make it available to the...